共 50 条
- [31] National Lung Matrix Trial: multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancerLUNG CANCER, 2015, 87 : S69 - S70Middleton, G.Billingham, L.Crack, L.Popat, S.Walker, I.
- [32] US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021JAMA INTERNAL MEDICINE, 2023, 183 (04) : 376 - 380Johnston, James L.Ross, Joseph S.Ramachandran, Reshma
- [33] Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomized controlled trialJOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 239 - 239Griesel, R.Zhao, Y.Simmons, B.Omar, Z.Hill, A.Meintjes, G.Maartens, G.
- [34] Results of an Open, Non-Comparative, Phase I/II Investigator Initiated Trial (IIT) in Relapsed or Refractory Multiple Myeloma Patients Using Vorinostat, Bortezomib, Doxorubicin and Dexamethasone (VBDD)BLOOD, 2015, 126 (23)Keller, AlexanderWaldschmidt, Johannes M.Wider, DagmarJakobs, DorotheeMoeller, MandyReinhardt, HeikePantic, MilenaGrishina, OlgaIhorst, GabrieleMay, Annette M.Frey, AnnaKohlweyer, UlrikeDuyster, JustusJung, ManfredEngelhardt, MonikaWaesch, Ralph
- [35] GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14Conduit, CiaraMak, BlossomQu, WenjiaDi Lulio, JulianaBurder, RonanBressel, MatthiasCusick, ThomasDhillon, Haryana M.Lourenco, Richard De AbreuUnderhill, CraigTorres, JavierCrumbaker, MeganHoneyball, FlorianLinton, AnthonyAllen, RayDavis, Ian D.Clark, Susan J.Horvath, Lisa G.Mahon, Kate L.
- [36] A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancerGYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 62 - 69Maria del Campo, JosepBirrer, MichaelDavis, CraigFujiwara, KeiichiGollerkeri, AshwinGore, MartinHouk, BrettLau, SusiePoveda, AndresGonzalez-Martin, AntonioMuller, CarolynMuro, KeiPierce, KristenSuzuki, MieVermette, JenniferOza, Amit
- [37] An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaINVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 249 - 253Hartmann, JTOechsle, KHuober, JJakob, AAzemar, MHorger, MKanz, LBokemeyer, C
- [38] A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trialLUNG CANCER, 2025, 202Soo, R. A.Vervita, K.Fruh, M.Cho, B. C.Majem, M.Abreu, D. RodriguezRibi, K.Callejo, A.Moran, T.Gomez, M. DomineProvencio, M.Addeo, A.Han, J. Y.Granados, A. L. OrtegaReck, M.Blasco, A.Campelo, R. GarciaGonzalez, M. A. SalaBritschgi, C.Roschitzki-Voser, H.Ruepp, B.Gasca-Ruchti, A.Haberecker, M.Dafni, U.Peters, S.Stahel, R. A.
- [39] Pivotal trial endpoints of drugs for rare and non-rare cancers in the US and EuropeANNALS OF ONCOLOGY, 2020, 31 : S1197 - S1197Vokinger, K. N.Daniore, P.Kesselheim, A. S.
- [40] A RANDOMIZED, NON-COMPARATIVE PHASE II TRIAL TO EXPLORE THE OPTIMAL ENDOSCOPIC ULTRASOUND-GUIDED TISSUE ACQUISITION METHOD FOR OBTAINING SPECIMEN FOR COMPREHENSIVE GENOMIC PROFILING IN PATIENTS WITH PANCREATIC CANCERGASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB856 - AB856Ishiwatari, HirotoshiSato, JunyaYasui, HirofumiYamazaki, KentaroOshima, KotoeFushiki, KunihiroKawakami, TakeshiHamauchi, SatoshiTsushima, TakahiroYokota, TomoyaOnozawa, YusukeSakamoto, HirokiDoi, TakuyaMatsubayashi, HiroyukiTakada, KazunoriMinamide, TatsunoriYamamoto, YoichiMaeda, YukiYoshida, MasaoIto, SayoKawata, NoboruImai, KenichiroHotta, KinichiNotsu, AkifumiNorose, TomokoOhike, NobuyukiOno, Hiroyuki